Thyrocare Technologies Ltd
Healthcare
Coronavirus: Pathology chains wait on the sidelines, device makers gear up
The number of confirmed coronavirus cases (COVID-19), which was declared a pandemic by the World Health Organization (WHO) last week, ......
Healthcare
Sector Watch: How PE-backed regional pathology chains stack up versus national peers
A few months after Thyrocare Technologies Ltd made a spectacular debut on stock exchanges, its founder A Velumani predicted that ......
Healthcare
How diagnostics companies can drive efficiency as price caps loom
With the spectre of the National Essential Diagnostics List and price caps looming over diagnostics industry, margins may come under ......
Healthcare
Diagnostics firms shouldn't fear price controls: Panellists at VCCircle summit
Diagnostics companies must focus on providing good-quality services and building sustainable business models instead of worrying about government moves to ......
Healthcare
Carlyle-backed Metropolis acquires four pathology labs
Pathology chain Metropolis Healthcare Ltd, which went public earlier this year, said it has acquired four labs to strengthen its ......
Healthcare
Metropolis Healthcare gains on trading debut after $174-mn IPO
Pathology chain owner Metropolis Healthcare Ltd made a strong debut on the stock markets on Monday with its shares listing ......
Healthcare
Carlyle-backed Metropolis' IPO subscribed almost six times on final day
Pathology chain owner Metropolis Healthcare Ltd’s initial public offering (IPO) was subscribed almost six times on the third and final ......
Healthcare
Carlyle-backed Metropolis Healthcare's IPO nears halfway mark on second day
Pathology chain owner Metropolis Healthcare Ltd’s initial public offering (IPO) nearly reached the halfway mark on its second day on ......
Healthcare
Diagnostics firms should still get fair valuation in IPOs: Thyrocare's Velumani
Thyrocare Technologies Ltd had made a spectacular debut on the stock exchanges two years ago. But its share prices have ......
Healthcare
Diagnostics sector still attractive to PEs: Thyrocare's Velumani at VCCircle event
The diagnostics sector continues to attract investor interest even as valuations have tempered over the past two years, a top ......
